RED STANOX (Stanozolol 10 mg)

RED STANOX (Stanozolol 10 mg) — the oral pyrazole androgen, in a precise 10 mg research unit
Stanozolol’s fused pyrazole ring is not a cosmetic modification — it is the structural reason the molecule survives first-pass metabolism and resists aromatisation. That makes the oral form a textbook subject for structure–activity work. RED STANOX supplies 100 batch-tested 10 mg tablets.

What is oral Stanozolol?

Stanozolol is a synthetic androgen derived from dihydrotestosterone in which a pyrazole ring is fused to the A-ring of the steroid nucleus, combined with 17α-methylation. The pyrazole system removes the 3-keto group that aromatase requires, so the compound cannot be converted to an oestrogen; the 17α-methyl group slows hepatic clearance enough that the compound remains orally bioavailable in the models where it has been studied. The result is one of the most structurally distinctive molecules in the androgen class, and a compound whose metabolites — 3′-hydroxystanozolol chief among them — are among the best-characterised in analytical toxicology. It is routinely used as a reference material in screening-assay validation.

Research interest

• Aromatase-independent signalling — studied as a ligand that cannot serve as an aromatase substrate, isolating androgenic pathways.
• Metabolite characterisation — a benchmark compound in research on hydroxylated and glucuronidated steroid metabolites.
• SHBG displacement — of interest to researchers examining carrier-protein binding and free-hormone fraction.
• Fibrinolysis research — has appeared in historical literature exploring effects on plasma fibrinolytic activity markers.
• Oral bioavailability models — investigated as a case study in how 17α-alkylation alters first-pass metabolism.

Specifications

• Content: 100 tablets × 10 mg
• Form: Solid oral tablets, sealed container
• Purity: Pharmaceutical-grade, batch-tested
• Storage: Cool, dry, away from light and humidity

Handling & storage

Store tablets in the original sealed container in a cool, dry place away from direct light and humidity. Moisture ingress is the principal stability risk for solid oral preparations, so keep the container tightly closed, avoid decanting into uncontrolled vessels and do not store near sinks, water baths or humidified incubators. Where tablets are crushed, weighed or dissolved for analytical work, do so in a ventilated enclosure with appropriate PPE and dedicated equipment to prevent cross-contamination of the bench. Record batch and lot numbers against every dataset, and route unused material and packaging through your institution’s chemical waste procedure. Keep out of reach of children, pets and untrained personnel.

Why source from Rogue

• Verified purity — every batch traceable and tested before it reaches a shelf.
• European supply chain — sealed blisters, authentic labelling, never grey-market.
• Discreet, tracked delivery — fast dispatch across the EU in unmarked packaging.

For research purposes only. Not a medicinal product. Not for human or veterinary consumption. Intended for qualified laboratory research use only.

Related: Orals · RED TRENO (Methyltrienolone 1 mg) · RED OXA (Oxandrolone 10 mg) · RED A-DROL (Oxymetholone 25 mg)